- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Imprimis Pharmaceuticals Inc
+ Add to WatchlistIMMY:US
9.6000 USD 0.4700 5.15%As of 20:10:00 ET on 05/24/2013.
Snapshot for Imprimis Pharmaceuticals Inc (IMMY)
| Open: | 9.2000 | Day's Range: | 8.7800 - 9.6290 | Volume: | 38,478 |
|---|---|---|---|---|---|
| Previous Close: | 9.6000 | 52wk Range: | 2.5500 - 30.0000 | 1-Yr Rtn: | +195.38% |
Key Statistics for IMMY
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 85.33 |
| Shares Outstanding (M) | 8.89 |
| 30 Day Average Volume | 31,507 |
| Price/Book (mrq) | 6.0228 |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | - |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for IMMY
No data available
Company Profile & Key Executives for IMMY
Imprimis Pharmaceuticals, Inc. is a pharmaceutical company that focuses on the development and commercialization of non-invasive topically delivered medications.
| Robert KammerChairman | Mark L BaumChief Executive Officer |
| Andrew BollVP Finance & Corporate Reporting | Joachim P H SchuppChief Medical Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
IMMY News
-
Industry News
No stories found
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page